Targeting Aging Ep3 - Rapamycin Benefits, Side Effects & Doses | Professor Matt Kaeberlein Interview

Professor Kaeberlein talks about rapamycin, what are the benefits that it has shown, some of the side effects and myths around them and what doses he is using in the Dog Aging Project. Dr. Matt Kaeberlein is a Professor of Pathology, Adjunct Professor of Genome Sciences, and Adjunct Professor of Oral Health Sciences at the University of Washington. His research interests are focused on basic mechanisms of aging in order to facilitate translational interventions that promote healthspan and improve quality of life. He is currently leading The Dog Aging project, a large multi-year trial to study the aging of companion dogs in a normal environment. He has published nearly 200 papers in top scientific journals and has been recognized by several prestigious awards, including a Breakthroughs in Gerontology Award, and most recent GSA’s 2020 Robert W. Kleemeier Award Professor Kaeberlein at University of Washington https://depts.washington.edu/mbwc/about/profile/matt-kaeberlein Dog Aging Project. https://dogagingproject.zendesk.com/hc/en-us #DogAgingProject #rapamycin #Healthspan